ANEXUS PHARMA LTD
Significant control: Scott Robert John Donald (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Anexus Pharma Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Anexus Pharma Ltd sell?
Registered activity: Management consultancy activities other than financial management (SIC 70229). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ANEXUS PHARMA LTD is an active private limited company (company number 11549994) incorporated on 3 September 2018, registered in Winchester. Its registered activity is management consultancy activities other than financial management (SIC 70229). Latest micro accounts cover the period ending 30 September 2025, showing net assets of £238k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 12% on the prior period (£271k).
By net assets it sits in the top quarter of 1,418 comparable companies in Southampton (median £5,326, upper quartile £40k).
Ownership and control
- Mr Scott Robert John Donald
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 3 September 20188 yrs ago
- Next accounts due
- 30 June 2027in 249 days
- Confirmation statement due
- 17 September 2027in 328 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 70229
- Management consultancy activities other than financial management
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £238k | — | — | £3,234 | — | — | 1 |
| 30 September 2024 | £271k | — | — | £8,955 | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £237,751 at 30 September 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 69.67
- Incorporated five or more years agoIncorporated 3 September 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 328 days
- Next accounts duein 249 days
- Accounts period endNet assets £238k · micro accounts
- Accounts period endNet assets £271k · micro accounts
- Incorporated
Similar companies in Southampton
- NRTS CONSULTANTS LTDSouthampton · inc. Sept 2018
- THREEFOLD SUSTAINABILITY LTDWinchester · inc. Sept 2018
- THE BUSINESS SKIPPER LIMITEDWinchester · inc. Sept 2018
- TRUST SAFETY SERVICES LIMITEDSouthampton · inc. Aug 2018
- EFE CONSULTANCY LIMITEDSouthampton · inc. Aug 2018
- IX HOLDINGS LTDEastleigh · inc. Sept 2018
All companies incorporated on 3 September 2018 · in Sept 2018.
Reminders for ANEXUS PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.